Pharmaceuticals in Dosage Market Size Value Per Capita in the UK

The Pharmaceuticals in Dosage market size value per capita in the UK showed a varied trend from 2012 to 2022. The market saw an initial increase from $1.28 thousand per capita in 2012 to a peak of $1.64 thousand per capita in 2015. Subsequently, there was a decline, reaching the lowest point at $0.9821 thousand per capita in 2022. Year-on-year, for 2023, the value stood slightly above $0.98 thousand per capita suggesting a stabilization phase. Comparing the last two years, a decrease of 7.54% in 2022 was recorded relative to 2021, and a slight increase of 8% in 2023. Over the last five years, the market shows a CAGR (Compound Annual Growth Rate) of -2.85%, indicating an overall negative growth trend during this period.

Future trends to watch for include potential improvements in pharmaceutical innovations and regulatory advancements, increased integration of personalized medicine which could boost market value, and a deeper focus on digital health solutions and telemedicine. Monitoring these elements will be crucial for anticipating market changes and capitalizing on arising opportunities.

How does the United Kingdom rank in Pharmaceuticals in Dosage Market Size Value Per Capita?

# 59 Countries US Dollars Per Capita Last Year
1 1 Italy 1,580 2023 View data
2 2 Germany 1,460 2023 View data
3 3 Denmark 1,300 2023 View data
4 4 Iceland 1,220 2023 View data
5 5 Norway 1,070 2023 View data
7 7 Austria 1,010 2023 View data
8 8 Israel 990.06 2023 View data
9 9 United Kingdom 969.43 2023
10 10 Spain 929.61 2023 View data
11 11 Canada 909.67 2023 View data

Top Countries about Generic Drug